Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic

Weiyi Tan1, Rushi V Parikh1, Rebecca Chester1

  • 1Division of Cardiology, University of California, Los Angeles, CA, USA.

Cardiology Research
|June 30, 2020
PubMed

Insights

The COVID-19 pandemic reduced cardiac catheterization volumes for acute coronary syndrome (ACS) and out-of-hospital cardiac arrest (OHCA) patients. However, ST-elevation myocardial infarction (STEMI) patients experienced no significant delays or increased mortality during this period.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly disrupted global healthcare delivery systems.
  • Understanding its impact on cardiovascular interventions, particularly for acute coronary syndrome (ACS), is crucial.
  • This study focuses on changes in cardiac catheterization procedures during the pandemic at a single institution.

Purpose of the Study:

  • To characterize the changes in cardiac catheterization volume and patient profiles for ACS during the COVID-19 pandemic.
  • To compare procedural characteristics and outcomes for ST-elevation myocardial infarction (STEMI) before and during the pandemic.
  • To assess the impact of the pandemic on out-of-hospital cardiac arrest (OHCA) interventions.

Main Methods:

  • Retrospective analysis of cardiac catheterization data from December 2019 to April 2020.
  • Inclusion criteria: ACS, STEMI activation, and OHCA patients.
  • Comparison of patient demographics, comorbidities, cardiac catheterization volumes, and procedural times between pre-pandemic and pandemic periods.

Main Results:

  • A 26% decrease in mean monthly ACS cases (STEMI and non-STEMI) was observed during the pandemic.
  • Significant reduction in OHCA cases (from 5/month to 0/month, P=0.01).
  • STEMI patients showed similar demographics, comorbidities, initial cardiac injury markers, door-to-balloon times, and all-cause mortality in both periods.

Conclusions:

  • Cardiac catheterization volumes for ACS spectrum conditions decreased during the initial COVID-19 pandemic phase, aligning with global trends.
  • Patients with STEMI did not experience presentation delays or increased mortality at this institution during the early pandemic.
  • The findings highlight the need for continued cardiac care amidst public health crises.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
281
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
530
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
149
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
130
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
189
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
229